{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:10:53Z","timestamp":1790244653835,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"KAKENHI","award":["23K24116"],"award-info":[{"award-number":["23K24116"]}]},{"name":"KAKENHI","award":["24K18413"],"award-info":[{"award-number":["24K18413"]}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Jikei University Graduate Research Fund"},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Jikei University Research Fund for Graduate Students"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04720-x","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:46:15Z","timestamp":1790243175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatocyte nuclear factor 4 alpha defines a distinct subtype of lung carcinoid with therapeutic potential targeting somatostatin receptor 2"],"prefix":"10.1007","author":[{"given":"Toshinori","family":"Otani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijitsu","family":"Ryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-6546","authenticated-orcid":false,"given":"Masayuki","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"6","key":"4720_CR1","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1530\/ERC-20-0036","volume":"27","author":"G Rindi","year":"2020","unstructured":"Rindi G, Inzani F (2020) Neuroendocrine neoplasm update: toward universal nomenclature. Endocr Relat Cancer 27(6):R211\u2013R218","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"4720_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA et al (2022) Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 33(1):115\u2013154","journal-title":"Endocr Pathol"},{"issue":"12","key":"4720_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.5858\/arpa.2024-0315-RA","volume":"149","author":"JC Hernandez-Prera","year":"2025","unstructured":"Hernandez-Prera JC, Riddle N, Gonzalez RS, Asa SL (2025) Endocrine and neuroendocrine tumors: updates from the 5th edition of the World Health Organization \u201cBlue Book.\u201d Arch Pathol Lab Med 149(12):1114\u20131135","journal-title":"Arch Pathol Lab Med"},{"key":"4720_CR4","volume-title":"Thoracic tumours","author":"WHO Classification of Tumours Editorial Board","year":"2021","unstructured":"WHO Classification of Tumours Editorial Board (2021) Thoracic tumours, 5th ed. International Agency for Research on Cancer (IARC), Lyon","edition":"5th ed"},{"issue":"1","key":"4720_CR5","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","volume":"10","author":"N Alcala","year":"2019","unstructured":"Alcala N, Leblay N, Gabriel AaG, Mangiante L, Hervas D, Giffon T et al (2019) Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun 10(1):3407","journal-title":"Nat Commun"},{"issue":"17","key":"4720_CR6","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-19-0214","volume":"79","author":"SV Laddha","year":"2019","unstructured":"Laddha SV, da Silva EM, Robzyk K, Untch BR, Ke H, Rekhtman N et al (2019) Integrative genomic characterization identifies molecular subtypes of lung carcinoids. Cancer Res 79(17):4339\u20134347","journal-title":"Cancer Res"},{"issue":"4","key":"4720_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jtho.2024.11.018","volume":"20","author":"DJG Leunissen","year":"2025","unstructured":"Leunissen DJG, Moonen L, Von Der Th\u00fcsen JH, Den Bakker MA, Hillen LM, Van Weert TJJ et al (2025) Identification of defined molecular subgroups on the basis of immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids. J Thorac Oncol 20(4):451\u2013464","journal-title":"J Thorac Oncol"},{"issue":"7563","key":"4720_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozreti\u0107 L, Kong G et al (2015) Comprehensive genomic profiles of small cell lung cancer. Nature 524(7563):47\u201353","journal-title":"Nature"},{"issue":"5","key":"4720_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J et al (2019) Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer 19(5):289\u2013297","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"4720_CR10","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","volume":"15","author":"MK Baine","year":"2020","unstructured":"Baine MK, Hsieh M-S, Lai WV, Egger JV, Jungbluth AA, Daneshbod Y et al (2020) SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization. J Thorac Oncol 15(12):1823\u20131835","journal-title":"J Thorac Oncol"},{"issue":"3","key":"4720_CR11","doi-asserted-by":"publisher","first-page":"100674","DOI":"10.1016\/j.modpat.2024.100674","volume":"38","author":"CA Febres-Aldana","year":"2025","unstructured":"Febres-Aldana CA, Elsayad MM, Saliba M, Bhanot U, Ntiamoah P, Takeyama A et al (2025) Analysis of ASCL1\/NEUROD1\/POU2F3\/YAP1 yields novel insights for the diagnosis of olfactory neuroblastoma and identifies sinonasal tuft cell\u2013like carcinoma. Mod Pathol 38(3):100674","journal-title":"Mod Pathol"},{"issue":"6","key":"4720_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ccr.2011.04.019","volume":"19","author":"KD Sutherland","year":"2011","unstructured":"Sutherland KD, Proost N, Brouns I, Adriaensen D, Song J-Y, Berns A (2011) Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell 19(6):754\u2013764","journal-title":"Cancer Cell"},{"issue":"3","key":"4720_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1084\/jem.20181155","volume":"216","author":"HJ Chen","year":"2019","unstructured":"Chen HJ, Poran A, Unni AM, Huang SX, Elemento O, Snoeck H-W et al (2019) Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med 216(3):674\u2013687","journal-title":"J Exp Med"},{"issue":"25","key":"4720_CR14","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1016\/j.cell.2022.11.005","volume":"185","author":"P He","year":"2022","unstructured":"He P, Lim K, Sun D, Pett JP, Jeng Q, Polanski K et al (2022) A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates. Cell 185(25):4841\u201360.e25","journal-title":"Cell"},{"issue":"12b","key":"4720_CR15","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1101\/gad.4.12b.2353","volume":"4","author":"FM Sladek","year":"1990","unstructured":"Sladek FM, Zhong WM, Lai E, Darnell JE (1990) Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4(12b):2353\u20132365","journal-title":"Genes Dev"},{"issue":"4","key":"4720_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12015-016-9709-x","volume":"13","author":"M Hanawa","year":"2017","unstructured":"Hanawa M, Takayama K, Sakurai F, Tachibana M, Mizuguchi H (2017) Hepatocyte nuclear factor 4 alpha promotes definitive endoderm differentiation from human induced pluripotent stem cells. Stem Cell Rev Rep 13(4):542\u2013551","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"4720_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s12276-020-00551-1","volume":"53","author":"D-D Lv","year":"2021","unstructured":"Lv D-D, Zhou L-Y, Tang H (2021) Hepatocyte nuclear factor 4\u03b1 and cancer-related cell signaling pathways: a promising insight into cancer treatment. Exp Mol Med 53(1):8\u201318","journal-title":"Exp Mol Med"},{"issue":"2","key":"4720_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/PAS.0b013e31826be303","volume":"37","author":"M Sugano","year":"2013","unstructured":"Sugano M, Nagasaka T, Sasaki E, Murakami Y, Hosoda W, Hida T et al (2013) HNF4\u03b1 as a Marker for Invasive Mucinous Adenocarcinoma of the Lung. Am J Surg Pathol 37(2):211\u2013218","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4720_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/his.15064","volume":"84","author":"WC Chang","year":"2024","unstructured":"Chang WC, Zhang YZ, Nicholson AG (2024) Pulmonary invasive mucinous adenocarcinoma. Histopathology 84(1):18\u201331","journal-title":"Histopathology"},{"issue":"6","key":"4720_CR20","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ccell.2024.05.002","volume":"42","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu C, Zheng S, Yao Y, Wang S, Wang X et al (2024) Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators. Cancer Cell 42(6):1106\u201325.e8","journal-title":"Cancer Cell"},{"issue":"10","key":"4720_CR21","doi-asserted-by":"publisher","first-page":"104210","DOI":"10.1016\/j.labinv.2025.104210","volume":"105","author":"K Asayama","year":"2025","unstructured":"Asayama K, Matsuoka R, Tachi S, Shiba-Ishii A, Murata Y, Nakagawa T et al (2025) Clinicopathologic, cellular, and molecular analyses of pulmonary neuroendocrine carcinoma with high expression of hepatocyte nuclear factor 4 Alpha. Lab Invest 105(10):104210","journal-title":"Lab Invest"},{"issue":"4","key":"4720_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/his.70055","volume":"88","author":"YP Hung","year":"2026","unstructured":"Hung YP, Wannasai K, Meador CB, Ganci ML, Rider AB, Wang CI et al (2026) Transcription factor-based subtype assignment in pulmonary large cell neuroendocrine carcinoma. Histopathology 88(4):810\u2013830","journal-title":"Histopathology"},{"issue":"6220","key":"4720_CR23","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A et al (2015) Tissue-based map of the human proteome. Science 347(6220):1260419","journal-title":"Science"},{"issue":"7","key":"4720_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.humpath.2004.02.016","volume":"35","author":"E Du","year":"2004","unstructured":"Du E (2004) TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35(7):825\u2013831","journal-title":"Hum Pathol"},{"issue":"7","key":"4720_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1634\/theoncologist.2017-0659","volume":"23","author":"O Lababede","year":"2018","unstructured":"Lababede O, Meziane MA (2018) The eighth edition of TNM staging of lung cancer: reference chart and diagrams. Oncologist 23(7):844\u2013848","journal-title":"Oncologist"},{"issue":"3","key":"4720_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2021","unstructured":"Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA et al (2021) The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol 17(3):362\u2013387","journal-title":"J Thorac Oncol"},{"issue":"6","key":"4720_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/PAS.0000000000001444","volume":"44","author":"R Sakakibara","year":"2020","unstructured":"Sakakibara R, Kobayashi M, Takahashi N, Inamura K, Ninomiya H, Wakejima R et al (2020) Insulinoma-associated Protein 1 (INSM1) is a better marker for the diagnosis and prognosis estimation of small cell lung carcinoma than neuroendocrine phenotype markers such as Chromogranin A, Synaptophysin, and CD56. Am J Surg Pathol 44(6):757\u2013764","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"4720_CR28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/modpathol.3800954","volume":"20","author":"M Volante","year":"2007","unstructured":"Volante M, Brizzi MP, Faggiano A, Rosa SL, Rapa I, Ferrero A et al (2007) Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20(11):1172\u20131182","journal-title":"Mod Pathol"},{"issue":"3","key":"4720_CR29","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.labinv.2024.102205","volume":"105","author":"A Sakyo","year":"2025","unstructured":"Sakyo A, Ryo E, Nishino S, Kobayashi K, Yoshimoto S, Omura G et al (2025) NKX3.1 helps distinguish hyalinizing clear cell carcinoma from other clear cell salivary gland neoplasms. Lab Invest 105(3):102205","journal-title":"Lab Invest"},{"issue":"3","key":"4720_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A et al (2020) The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol 38(3):276\u2013278","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4720_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"P Di Tommaso","year":"2017","unstructured":"Di Tommaso P, Chatzou M, Floden EW, Barja PP, Palumbo E, Notredame C (2017) Nextflow enables reproducible computational workflows. Nat Biotechnol 35(4):316\u2013319","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4720_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321","journal-title":"Bioinformatics"},{"issue":"1","key":"4720_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12(1):323","journal-title":"BMC Bioinformatics"},{"issue":"16","key":"4720_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al (2009) The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25(16):2078\u20132079","journal-title":"Bioinformatics"},{"issue":"1","key":"4720_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) EdgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139\u2013140","journal-title":"Bioinformatics"},{"issue":"1","key":"4720_CR36","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O et al (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523","journal-title":"Nat Commun"},{"issue":"11","key":"4720_CR37","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1111\/j.1582-4934.2010.01125.x","volume":"14","author":"M Cakir","year":"2010","unstructured":"Cakir M, Dworakowska D, Grossman A (2010) Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 \u2013 molecular pathways. J Cell Mol Med 14(11):2570\u20132584","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4720_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000517530","volume":"112","author":"J Yu","year":"2022","unstructured":"Yu J, Cao F, Zhao X, Xie Q, Lu M, Li J et al (2022) Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography\/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms. Neuroendocrinology 112(4):358\u2013369","journal-title":"Neuroendocrinology"},{"issue":"10446","key":"4720_CR39","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"S Singh","year":"2024","unstructured":"Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL et al (2024) [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2\u20133, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. The Lancet 403(10446):2807\u20132817","journal-title":"The Lancet"},{"issue":"1","key":"4720_CR40","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/s41598-024-54599-4","volume":"14","author":"JY Kim","year":"2024","unstructured":"Kim JY, Kim J, Kim Y-I, Yang D-H, Yoo C, Park IJ et al (2024) Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors. Sci Rep 14(1):4047","journal-title":"Sci Rep"},{"issue":"5662","key":"4720_CR41","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1126\/science.1089769","volume":"303","author":"DT Odom","year":"2004","unstructured":"Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL et al (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303(5662):1378\u20131381","journal-title":"Science"},{"issue":"1","key":"4720_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/endrev\/bnae022","volume":"46","author":"B Zhang","year":"2025","unstructured":"Zhang B, Xue L, Wu ZB (2025) Structure and function of somatostatin and its receptors in endocrinology. Endocr Rev 46(1):26\u201342","journal-title":"Endocr Rev"},{"issue":"1","key":"4720_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40169-019-0238-5","volume":"8","author":"M Torniai","year":"2019","unstructured":"Torniai M, Scortichini L, Tronconi F, Rubini C, Morgese F, Rinaldi S et al (2019) Systemic treatment for lung carcinoids: from bench to bedside. Clin Transl Med 8(1):22","journal-title":"Clin Transl Med"},{"issue":"12","key":"4720_CR44","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1007\/s00259-022-05848-z","volume":"49","author":"V Rufini","year":"2022","unstructured":"Rufini V, Lorusso M, Inzani F, Pasciuto T, Triumbari EKA, Grillo LR et al (2022) Correlation of somatostatin receptor PET\/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study. Eur J Nucl Med Mol Imaging 49(12):4182\u20134193","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04720-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04720-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04720-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:46:17Z","timestamp":1790243177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04720-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":44,"alternative-id":["4720"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04720-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional ethics committee at the Jikei University Hospital approved this study, conducted in accordance with the Declaration of Helsinki (approval no. 33\u2013123 (10738)). The requirement for written informed consent was waived because of the retrospective use of archived human specimens; however, all patients could opt out.","order":1,"name":"Ethics","label":"Compliance with ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}